A Study to Evaluate Flexible Dose of Paliperidone Extended Release (ER) and Clinical Response in Participants With Schizophrenia

NCT01577160 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

353

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Paliperidone ER

Sponsor

Johnson & Johnson Taiwan Ltd